Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

30results about How to "Take a lot of medicine" patented technology

Preparation method of Yikangbuyuan tablet and application of Yikangbuyuan tablet in medicines for inhibiting mouse lymphoid cancer cell P388D1 proliferation

InactiveCN103655841AEasy to acceptTake a lot of medicinePill deliveryAntineoplastic agentsCancer cellMichelia hedyosperma
The invention belongs to the technical field of traditional Chinese medicines, and particularly provides a preparation method and application of a Yikangbuyuan tablet. The Yikangbuyuan tablet is prepared from 280g of radix astragali, 80g of Michelia hedyosperma Lew, 190g of angelica, 220g of yerbadetajo, 190g of rhizoma atractylodis, 150g of safflower, 140g of red paeonia, 140g of peach kernel, 150g of radix achyranthis bidentatae, 120g of hemlock parsley, 70g of fructus aurantii and 100g of balloonflower by supercritical extraction and microwave extraction, so that the penoniflorin content is greatly enhanced. The invention also provides application of the Yikangbuyuan tablet in preparing medicines for inhibiting mouse lymphoid cancer cell P388D1 proliferation.
Owner:刘伟伟

Preparation method of Yikangbuyuan tablet and application of Yikangbuyuan tablet in medicines for inhibiting mouse leukaemia cell L6565 proliferation

ActiveCN103690647AEasy to acceptTake a lot of medicinePill deliveryAntineoplastic agentsMichelia hedyospermaActive ingredient
The invention belongs to the technical field of traditional Chinese medicines, and particularly provides a preparation method and application of a Yikangbuyuan tablet. The Yikangbuyuan tablet is prepared from 280g of radix astragali, 80g of Michelia hedyosperma Lew, 190g of angelica, 220g of yerbadetajo, 190g of rhizoma atractylodis, 150g of safflower, 140g of red paeonia, 140g of peach kernel, 150g of radix achyranthis bidentatae, 120g of hemlock parsley, 70g of fructus aurantii and 100g of balloonflower by supercritical extraction and microwave extraction, so that the penoniflorin content is greatly enhanced. The invention also provides application of the Yikangbuyuan tablet in preparing medicines for inhibiting mouse mononuclear macrophage leukaemia cell L6565 proliferation.
Owner:烟台力量知识产权服务有限公司

Preparation method of cold tablet containing Artemisia carvifolia and holly root, and application of cold tablet in teratoma cell F9 cell proliferation inhibition medicines.

InactiveCN103751424ATake a lot of medicineSmall dosePill deliveryAntineoplastic agentsLicorice rootsArtemisia carvifolia
The invention belongs to the technical field of traditional Chinese medicines, and concretely relates to a preparation method of a cold tablet containing Artemisia carvifolia and holly root, and an application of the cold tablet. The preparation method of the cold tablet containing Artemisia carvifolia and holly root is characterized in that the cold tablet is prepared by using 200g of Artemisia carvifolia, 267g of Fructus Citri Sarcodactylis, 134g of Herba Moslae, 200g of Dicliptera chinensis, 134g of licorice root, 134g of Centella asiatica and 267g of holly root as raw medicines through supercritical extraction and microwave extraction, so the glycyrrhizic acid content is greatly improved. The invention also provides an application of the cold tablet containing Artemisia carvifolia and holly root in the preparation of teratoma cell F9 cell proliferation inhibition medicines.
Owner:JINAN XINQIDIAN MEDICAL TECH

Preparation method of Qingmei cold tablet and application of Qingmei cold tablet in drugs for inhibiting lung cancer cell H22 from cell proliferation

InactiveCN103768267ATake a lot of medicineSmall doseDigestive systemPill deliveryAdditive ingredientMedicine
The invention belongs to the technical field of traditional Chinese medicines, and particularly provides a preparation method and application of a Qingmei cold tablet. The preparation method comprises the following steps: by using 200g of southernwood, 267g of finger citron, 134g of elsholtzia, 200g of dicliptera, 134g of licorice, 134g of cat's-foot and 267g of holly root as active pharmaceutical ingredients, carrying out supercritical extraction and microwave extraction so that the glycyrrhizic acid content is greatly enhanced. The invention also provides application of the Qingmei cold tablet in preparing drugs for inhibiting mouse liver cancer cell H22 from cell proliferation.
Owner:JINAN XINQIDIAN MEDICAL TECH

Preparation method of Qingmei cold tablet and application of Qingmei cold tablet in drugs for inhibiting melanoma cell B16 from cell proliferation

InactiveCN103800499ATake a lot of medicineSmall doseAntipyreticAnalgesicsMicrowaveMedicine
The invention belongs to the technical field of traditional Chinese medicines, and particularly provides a preparation method and application of a Qingmei cold tablet. The preparation method comprises the following steps: by using 200g of southernwood, 267g of finger citron, 134g of elsholtzia, 200g of dicliptera, 134g of licorice, 134g of cat's-foot and 267g of holly root as active pharmaceutical ingredients, carrying out supercritical extraction and microwave extraction so that the glycyrrhizic acid content is greatly enhanced. The invention also provides application of the Qingmei cold tablet in preparing drugs for inhibiting mouse melanoma cell B16 from cell proliferation.
Owner:JINAN XINQIDIAN MEDICAL TECH

Preparation method and application of green plum cold tablets

InactiveCN103893411ATake a lot of medicineSmall dosePill deliveryAntineoplastic agentsMicrowaveLiquorices
The invention belongs to the technical field of traditional Chinese medicaments, and in particular relates to a preparation method and application of green plum cold tablets. According to the preparation method, the cold tablets are prepared by using 200g of sweet wormwood, 267g of herba viticis, 134g of herba moslae, 200g of dicliptera chinensis, 134g of liquorice, 134g of centella and 267g of roughhaired holly root as raw medicinal materials and adopting supercritical extraction and microwave extraction, so that the content of glycyrrhizic acid can be greatly increased. The invention also provides application of the green plum cold tablets in preparation of medicaments for inhibiting cell proliferation of a leukemia cell RAW264.7 of mouse mononuclear macrophage.
Owner:JINAN XINQIDIAN MEDICAL TECH

Preparation method of Yikangbuyuan tablet and application of Yikangbuyuan tablet in medicines for inhibiting mouse lymphomata cell EL4. IL-2 proliferation

InactiveCN103655842AEasy to acceptTake a lot of medicineNervous disorderDigestive systemMichelia hedyospermaActive ingredient
The invention belongs to the technical field of traditional Chinese medicines, and particularly provides a preparation method and application of a Yikangbuyuan tablet. The Yikangbuyuan tablet is prepared from 280g of radix astragali, 80g of Michelia hedyosperma Lew, 190g of angelica, 220g of yerbadetajo, 190g of rhizoma atractylodis, 150g of safflower, 140g of red paeonia, 140g of peach kernel, 150g of radix achyranthis bidentatae, 120g of hemlock parsley, 70g of fructus aurantii and 100g of balloonflower by supercritical extraction and microwave extraction, so that the penoniflorin content is greatly enhanced. The invention also provides application of the Yikangbuyuan tablet in preparing medicines for inhibiting mouse lymphomata cell EL4. IL-2 proliferation.
Owner:冯向英

Preparation method of Danshitongli tablet and application of Danshitongli tablet in preparing drugs for inhibiting stomach cancer cell MFC from cell proliferation

InactiveCN103768516ATake a lot of medicineReduce dosagePill deliveryAluminium/calcium/magnesium active ingredientsMyrrhGardenia
The invention belongs to the technical field of traditional Chinese medicines, and particularly provides a preparation method and application of a Danshitongli tablet. The preparation method comprises the following steps: by using 225g of Herba Lysimachiae, 225g of oriental wormwood, 90g of radix curcumae, 150g of dried orange peel, 45g of radix scutellariae, 35g of frankincense, 80g of mirabilite, 35 of white alum, 45g of rhubarb, 45g of rhizoma sparganii, 45g of gardenia, 25g of licorice and 35g of myrrh as active pharmaceutical ingredients, carrying out superfine grinding, supercritical extraction, microwave extraction and macroporous resin adsorption so that the hesperidin content is greatly enhanced. The invention also provides application of the Danshitongli tablet in preparing drugs for inhibiting mouse cerebral nerve tumor cell Neuro-2a from cell proliferation.
Owner:JINAN XINQIDIAN MEDICAL TECH

Danshilitong tablet preparation method and application of Danshilitong tablets in preparation of lymphoid neoplasm cell P388D1 proliferation inhibition drugs

InactiveCN103751700ATake a lot of medicineReduce dosageDigestive systemPill deliveryMyrrhUltra fine
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a preparation method and an application of Danshilitong tablets, wherein the Danshilitong tablets are prepared by adopting 225 g of dichondra repens forst, 225 g of artemisiacapillaris thunb, 90 g of curcuma aromatica salisb, 150 g of tangerine peel, 45 g of scutellaria baicalensis georgi, 35 g of boswellia carteri, 80 g of mirabilite, 35 g of alunite, 45 g of rheum, 45 g of common burreed tuber, 45 g of cape jasmine, 25 g of licorice root, and 35 g of myrrh as bulk drugs. According to the prevent invention, ultra-fine crushing, supercritical fluid extraction, microwave extraction and macroporous resin absorption are performed to prepare the Danshilitong tablets, such that the hesperidin content is substantially increased. The present invention further provides the application of the Danshilitong tablets in preparation of mouse lymphoid neoplasm cell P388D1 proliferation inhibition drugs.
Owner:JINAN XINQIDIAN MEDICAL TECH

Application of dizziness-relieving and calming tablet in preparing medicine for inhibiting cell proliferation of embryonal carcinoma cell F9

InactiveCN103800871ATake a lot of medicineSmall dosePill deliveryAntineoplastic agentsEmbryonal Carcinoma CellsEpimedium
The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to application of a dizziness-relieving and calming tablet in preparing a medicine for inhibiting cell proliferation of an embryonal carcinoma cell F9 and a preparation method of the dizziness-relieving and calming tablet. According to the application of the dizziness-relieving and calming tablet in preparing the medicine for inhibiting cell proliferation of the embryonal carcinoma cell F9, the dizziness-relieving and calming tablet is prepared from the following bulk drugs: 400g of pyrola, 160g of epimedium, 160g of astragalus membranaceus, 140g of Chinese angelica, 200g of ligusticum wallichii, 240g of kudzu vine root, 120g of fried bighead atractylodes rhizome, 140g of spina date seed, 120g of prepared pinellia ternata, 120g of rhizoma alismatis, 100g of dried ginger, and 100g of liquorice. The dizziness-relieving and calming tablet is prepared by adopting supercritical extraction and microwave extraction, so that the content of icariin can be greatly improved.
Owner:JINAN XINQIDIAN MEDICAL TECH

Application of lawn pennywort herb liver healing tablet in preparation of medicine for inhibiting proliferation of breast ductal carcinoma cells T47D

InactiveCN105770025ATake a lot of medicineReduce dosagePharmaceutical non-active ingredientsPill deliveryT47d cellCancer cell
The invention belongs to the technical field of traditional Chinese medicine, and in particular relates to application of a lawn pennywort herb liver healing tablet in preparation of medicine for inhibiting proliferation of breast ductal carcinoma cells T47D and a method for preparing the lawn pennywort herb liver healing tablet. The lawn pennywort herb is made by using 699g of lawn pennywort herb, 1398g of candolle pimpinella, 699g of oxalis corniculata and 209g of anemone rivularis as raw medicinal materials and is prepared by adopting supercritical extraction, such that the content of oleanolic acid is greatly improved.
Owner:JINAN XINSHIDAI MEDICINE SCI & TECH

Preparation method of Danshitongli tablet and application of Danshitongli tablet in preparing drugs for inhibiting myeloma cell SP2/0 from cell proliferation

InactiveCN103768514ATake a lot of medicineReduce dosagePharmaceutical product form changePill deliveryMyrrhMirabilitum
The invention belongs to the technical field of traditional Chinese medicines, and particularly provides a preparation method and application of a Danshitongli tablet. The preparation method comprises the following steps: by using 225g of Herba Lysimachiae, 225g of oriental wormwood, 90g of radix curcumae, 150g of dried orange peel, 45g of radix scutellariae, 35g of frankincense, 80g of mirabilite, 35 of white alum, 45g of rhubarb, 45g of rhizoma sparganii, 45g of gardenia, 25g of licorice and 35g of myrrh as active pharmaceutical ingredients, carrying out superfine grinding, supercritical extraction, microwave extraction and macroporous resin adsorption so that the hesperidin content is greatly enhanced. The invention also provides application of the Danshitongli tablet in preparing drugs for inhibiting myeloma cell SP2 / 0 from cell proliferation.
Owner:JINAN XINQIDIAN MEDICAL TECH

Preparation method of Huixinkang tablets and application thereof in anus sarcoma cell S-180 cell proliferation inhibition drugs

InactiveCN104095963ATake a lot of medicineSmall dosePill deliveryAntineoplastic agentsRhodobryumAnus
The invention belongs to the technical field of traditional Chinese medicine, particularly to a preparation method of Huixinkang tablets and application thereof. According to the preparation method of Huixinkang tablets, the Huixinkang tablets provided by the invention are prepared through adopting supercritical fluid extraction and microwave-assisted extraction of the following components as the pharmaceutical raw materials: 780 g of uncaria, 910 g of red rhodobryum, 26 g of polygonum multiflorum, 260 g of astragalus membranaceus, 26 g of panax notoginseng, 650 g of hawthorn and 260 g of glycyrrhiza, so that the ginsenoside Rg1 content is greatly increased through adopting the method. The invention further provides the application of the Huixinkang tablets in the preparation of anus sarcoma cell S-180 cell proliferation inhibition drugs.
Owner:关军

Application of lespedeza cuneata turbidity removing tablet in preparation of medicine for inhibiting cell proliferation of embryonal carcinoma F9

InactiveCN103705825ATake a lot of medicineSmall doseAnthropod material medical ingredientsPill deliveryEmbryonal carcinomaGLYCYRRHIZA EXTRACT
The invention belongs to the technical field of traditional Chinese medicines, and specifically relates to an application of a lespedeza cuneata turbidity removing tablet in preparation of a medicine for inhibiting cell proliferation of embryonal carcinoma F9 as well as a preparation method of the lespedeza cuneata turbidity removing tablet. According to the application of the lespedeza cuneata turbidity removing tablet in preparation of the medicine for inhibiting cell proliferation of embryonal carcinoma F9, the lespedeza cuneata turbidity removing tablet is prepared from the following raw material medicines: 417g of cleavers, 417g of lespedeza cuneata, 333g of rhizoma dioscoreae hypoglaucae, 417g of houttuynia cordata, 417g of dandelion, 250g of silky ants, 417g of fructus akebiae, 250g of semen plantaginis, 250g of poria cocos, 250g of Chinese yam, 167g of alpinia oxyphylla, 250g of semen cuscutae, 250g of flatstem milkvetch seeds, 333g of cherokee rose roots, 125g of polygala tenuifolia and 50g of liquorice. The tablet is prepared by supercritical extraction and microwave extraction, so that the content of diosgenin is greatly improved.
Owner:滨州市人民医院

Preparation method of Danshitongli tablet and application of Danshitongli tablet in preparing drugs for inhibiting myeloma cell SP2/0 from cell proliferation

InactiveCN103768510ATake a lot of medicineReduce dosagePill deliveryAluminium/calcium/magnesium active ingredientsMyrrhAdditive ingredient
The invention belongs to the technical field of traditional Chinese medicines, and particularly provides a preparation method and application of a Danshitongli tablet. The preparation method comprises the following steps: by using 225g of Herba Lysimachiae, 225g of oriental wormwood, 90g of radix curcumae, 150g of dried orange peel, 45g of radix scutellariae, 35g of frankincense, 80g of mirabilite, 35 of white alum, 45g of rhubarb, 45g of rhizoma sparganii, 45g of gardenia, 25g of licorice and 35g of myrrh as active pharmaceutical ingredients, carrying out superfine grinding, supercritical extraction, microwave extraction and macroporous resin adsorption so that the hesperidin content is greatly enhanced. The invention also provides application of the Danshitongli tablet in preparing drugs for inhibiting myeloma cell SP2 / 0 from cell proliferation.
Owner:JINAN XINQIDIAN MEDICAL TECH

Application of herba hydrocotylis liver-curing tablets in preparation of medicine for inhibiting cell proliferation of lymphoma cell U-937

InactiveCN105596448ATake a lot of medicineReduce dosagePill deliveryAntineoplastic agentsMedicinePharmaceutical drug
The invention belongs to the technical field of traditional Chinese medicines and particularly relates to an application of herba hydrocotylis liver-curing tablets in preparation of a medicine for inhibiting the cell proliferation of lymphoma cell U-937 and a preparation method of herba hydrocotylis liver-curing tablets. The herba hydrocotylis liver-curing tablets are prepared from the active pharmaceutical ingredients including 699g of herba hydrocotylis, 1,398g of herba pimpinellae, 699g of oxalis corniculata and 209g of brooklet anemone root by supercritical extraction, wherein the content of oleanolic acid is greatly increased.
Owner:JINAN XINSHIDAI MEDICINE SCI & TECH

Preparation method of Danshitongli tablet and application of Danshitongli tablet in preparing drugs for inhibiting Leydig's cell tumor cell MLTC-1 from cell proliferation

InactiveCN103768509ATake a lot of medicineReduce dosagePill deliveryAluminium/calcium/magnesium active ingredientsMyrrhAdditive ingredient
The invention belongs to the technical field of traditional Chinese medicines, and particularly provides a preparation method and application of a Danshitongli tablet. The preparation method comprises the following steps: by using 225g of Herba Lysimachiae, 225g of oriental wormwood, 90g of radix curcumae, 150g of dried orange peel, 45g of radix scutellariae, 35g of frankincense, 80g of mirabilite, 35 of white alum, 45g of rhubarb, 45g of rhizoma sparganii, 45g of gardenia, 25g of licorice and 35g of myrrh as active pharmaceutical ingredients, carrying out superfine grinding, supercritical extraction, microwave extraction and macroporous resin adsorption so that the hesperidin content is greatly enhanced. The invention also provides application of the Danshitongli tablet in preparing drugs for inhibiting Leydig's cell tumor cell MLTC-1 from cell proliferation.
Owner:JINAN XINQIDIAN MEDICAL TECH

Preparation method of Danshitongli tablet and application of Danshitongli tablet in preparing drugs for inhibiting lung cancer cell Hepa1-6 from cell proliferation

InactiveCN103800819ATake a lot of medicineReduce dosagePill deliveryAluminium/calcium/magnesium active ingredientsMyrrhGardenia
The invention belongs to the technical field of traditional Chinese medicines, and particularly provides a preparation method and application of a Danshitongli tablet. The preparation method comprises the following steps: by using 225g of Herba Lysimachiae, 225g of oriental wormwood, 90g of radix curcumae, 150g of dried orange peel, 45g of radix scutellariae, 35g of frankincense, 80g of mirabilite, 35 of white alum, 45g of rhubarb, 45g of rhizoma sparganii, 45g of gardenia, 25g of licorice and 35g of myrrh as active pharmaceutical ingredients, carrying out superfine grinding, supercritical extraction, microwave extraction and macroporous resin adsorption so that the hesperidin content is greatly enhanced. The invention also provides application of the Danshitongli tablet in preparing drugs for inhibiting mouse liver cancer cell Hepa1-6 from cell proliferation.
Owner:JINAN XINQIDIAN MEDICAL TECH

Application of hydrocotyle sibthorpioides herb liver healing tablet in preparation of medicament for inhibiting cell proliferation of laryngeal epidermoid carcinoma cells HEp-2

InactiveCN105770030ATake a lot of medicineReduce dosagePill deliveryAntineoplastic agentsTraditional medicineActive ingredient
The invention belongs to the technical field of traditional Chinese medicine and in particular relates to application of a hydrocotyle sibthorpioides herb liver healing tablet in preparation of medicament for inhibiting cell proliferation of laryngeal epidermoid carcinoma cells HEp-2 and a preparation method of the hydrocotyle sibthorpioides herb liver healing tablet. The hydrocotyle sibthorpioides herb liver healing tablet is prepared from active pharmaceutical ingredients of 699g of hydrocotyle sibthorpioides herb, 1398g of herba pimpinellae, 699g of herba oxalidis corniculatae and 209g of brooklet anemone root by adopting supercritical extraction, so that the content of oleanolic acid is greatly improved.
Owner:JINAN XINSHIDAI MEDICINE SCI & TECH

A kind of pharmaceutical composition for treating affective mental disorders

ActiveCN103550778BSolving Difficult Treatment ProblemsImprove efficacyNervous disorderAnhydride/acid/halide active ingredientsDiseaseSide effect
The invention provides a pharmaceutical composition comprising a 5-HT1A receptor stimulant and a mood stabilizer. In the pharmaceutical composition, the weight ratio of the 5-HT1A receptor stimulant to the mood stabilizer is (1-40):(50-800). The invention also provides application of the pharmaceutical composition. Through combination of selective 5-HT1A receptor stimulant and the mood stabilizer which have different action mechanisms, the drug can treat anxiety, depression and / or biphasic emotional disorder and the like at the same time; the disease treatment spectrum is wider; furthermore, the curative effect after combination is more significant than that of single medicine, and the toxic and side effects are lower; a novel drug selection is provided to patients who are intolerant to first-line anti-anxiety or anti-depression or drugs.
A kind of pharmaceutical composition for treating affective mental disorders
A kind of pharmaceutical composition for treating affective mental disorders
A kind of pharmaceutical composition for treating affective mental disorders
View all
Owner:SICHUAN CREDIT PHARMA

Preparation method of Danshitongli tablet and application of Danshitongli tablet in preparing drugs for inhibiting teratoma cell P19 from cell proliferation

InactiveCN103768513ATake a lot of medicineReduce dosagePill deliveryAluminium/calcium/magnesium active ingredientsMyrrhGardenia
The invention belongs to the technical field of traditional Chinese medicines, and particularly provides a preparation method and application of a Danshitongli tablet. The preparation method comprises the following steps: by using 225g of Herba Lysimachiae, 225g of oriental wormwood, 90g of radix curcumae, 150g of dried orange peel, 45g of radix scutellariae, 35g of frankincense, 80g of mirabilite, 35 of white alum, 45g of rhubarb, 45g of rhizoma sparganii, 45g of gardenia, 25g of licorice and 35g of myrrh as active pharmaceutical ingredients, carrying out superfine grinding, supercritical extraction, microwave extraction and macroporous resin adsorption so that the hesperidin content is greatly enhanced. The invention also provides application of the Danshitongli tablet in preparing drugs for inhibiting mouse teratoma cell P19 from cell proliferation.
Owner:THE AFFILIATED HOSPITAL OF QINGDAO UNIV

Application of Tiezhou Qingzhuo tablets to preparation of medicine for inhibiting cell proliferation of melanoma cell B16

InactiveCN103690863ATake a lot of medicineSmall doseAnthropod material medical ingredientsPill deliveryMelanomaAlpinia oxyphylla
The invention belongs to the technical field of traditional Chinese medicines and in particular relates to application of Tiezhou Qingzhuo tablets to preparation of a medicine for inhibiting cell proliferation of melanoma cell B16 and a preparation method of the Tiezhou Qingzhuo tablets. According to the application of the Tiezhou Qingzhuo tablets to preparation of the medicine for inhibiting cell proliferation of melanoma cell B16, the Tiezhou Qingzhuo tablets are prepared from the following raw material medicines: 417 g of cleavers, 417 g of Lespedeza cuneata, 333 g of rhizoma dioscoreae hypoglaucae, 417 g of Houttuynia cordata, 417 g of dandelion, 250 g of black ant, 417 g of Akebia Fruit, 250 g of semen plantaginis, 250 g of Tuckahoe, 250 g of Chinese yam, 167 g of Alpinia oxyphylla, 250 g of semen cuscutae, 250 g of flatstem milkvetch seed, 333 g of cherokee rose root, 125 g of polygala tenuifolia and 50 g of liquorice, and are prepared by supercritical extraction and microwave extraction, so that the diosgenin content is greatly increased.
Owner:徐桂娟

Preparation method of Yikangbuyuan tablet and application of Yikangbuyuan tablet in medicines for inhibiting mouse leukaemia cell L1210 proliferation

InactiveCN103655840AEasy to acceptTake a lot of medicineDigestive systemPill deliveryMedicineL1210 cell
The invention belongs to the technical field of traditional Chinese medicines, and particularly provides a preparation method and application of a Yikangbuyuan tablet. The Yikangbuyuan tablet is prepared from 280g of radix astragali, 80g of Michelia hedyosperma Lew, 190g of angelica, 220g of yerbadetajo, 190g of rhizoma atractylodis, 150g of safflower, 140g of red paeonia, 140g of peach kernel, 150g of radix achyranthis bidentatae, 120g of hemlock parsley, 70g of fructus aurantii and 100g of balloonflower by supercritical extraction and microwave extraction, so that the penoniflorin content is greatly enhanced. The invention also provides application of the Yikangbuyuan tablet in preparing medicines for inhibiting mouse leukaemia cell L1210 proliferation.
Owner:周武元

Application of herba hydrocotylis liver-curing tablets in preparation of medicine for inhibiting cell proliferation of melanoma cell A875

InactiveCN105596451ATake a lot of medicineReduce dosagePill deliveryAntineoplastic agentsMelanomaActive ingredient
The invention belongs to the technical field of traditional Chinese medicines and particularly relates to an application of herba hydrocotylis liver-curing tablets in preparation of a medicine for inhibiting cell proliferation of the melanoma cell A875 and a preparation method of herba hydrocotylis liver-curing tablets. The herba hydrocotylis liver-curing tablets are prepared from the active pharmaceutical ingredients including 699g of herba hydrocotylis, 1,398g of herba pimpinellae, 699g of oxalis corniculata and 209g of brooklet anemone root by supercritical extraction, wherein the content of oleanolic acid is greatly increased.
Owner:JINAN XINSHIDAI MEDICINE SCI & TECH

Application of lawn pennywort herb liver healing tablet in preparation of medicine for inhibiting proliferation of cutaneous melanoma cells A375

InactiveCN105770029ATake a lot of medicineReduce dosagePill deliveryPharmaceutical non-active ingredientsAsiatic pennywortSaposhnikovia
The invention belongs to the technical field of traditional Chinese medicine, and in particular relates to application of a lawn pennywort herb liver healing tablet in preparation of medicine for inhibiting proliferation of cutaneous melanoma cells A375 and a method for preparing the lawn pennywort herb liver healing tablet. The lawn pennywort herb is made by using 699g of lawn pennywort herb, 1398g of candolle pimpinella, 699g of oxalis corniculata and 209g of anemone rivularis as raw medicinal materials and is prepared by adopting supercritical extraction, such that the content of oleanolic acid is greatly improved.
Owner:JINAN XINSHIDAI MEDICINE SCI & TECH

Preparation method of cold tablet containing Artemisia carvifolia and holly root, and application of cold tablet in mastocytoma cell P815 cell proliferation inhibition medicines

InactiveCN103751423ATake a lot of medicineSmall dosePill deliveryRespiratory disorderMastocytoma cellP815 cell
The invention belongs to the technical field of traditional Chinese medicines, and concretely relates to a preparation method of a cold tablet containing Artemisia carvifolia and holly root, and an application of the cold tablet. The preparation method of the cold tablet containing Artemisia carvifolia and holly root is characterized in that the cold tablet is prepared by using 200g of Artemisia carvifolia, 267g of Fructus Citri Sarcodactylis, 134g of Herba Moslae, 200g of Dicliptera chinensis, 134g of licorice root, 134g of Centella asiatica and 267g of holly root as raw medicines through supercritical extraction and microwave extraction, so the glycyrrhizic acid content is greatly improved. The invention also provides an application of the cold tablet in the preparation of mastocytoma cell P815 cell proliferation inhibition medicines.
Owner:JINAN XINQIDIAN MEDICAL TECH

Application of lawn pennywort herb liver-healing tablets in preparation of drug for inhibiting cell proliferation of osteosarcoma cells HOS

InactiveCN105816535ATake a lot of medicineReduce dosagePill deliveryAntineoplastic agentsMedicineTraditional medicine
The invention belongs to the technical field of traditional Chinese medicine, and particularly relates to application of lawn pennywort herb liver-healing tablets in preparation of a drug for inhibiting cell proliferation of osteosarcoma cells HOS and a preparation method of the lawn pennywort herb liver-healing tablets.The lawn pennywort herb liver-healing tablets are prepared from 699 g of lawn pennywort herb, 1,398 g of herba pimpinellae, 699 g of creeping woodsorrel herb and 209 g of brooklet anemone roots.The lawn pennywort herb liver-healing tablets are prepared by means of supercritical extraction, and the content of oleanolic acid is greatly increased.
Owner:JINAN XINSHIDAI MEDICINE SCI & TECH

Application of lawn pennywort herb liver healing tablet in preparation of medicine for inhibiting proliferation of colon cancer cell LoVo

InactiveCN105770027ATake a lot of medicineReduce dosagePill deliveryAntineoplastic agentsColon cancer cellActive ingredient
The invention belongs to the technical field of traditional Chinese medicine, and in particular relates to application of a lawn pennywort herb liver healing tablet in preparation of medicine for inhibiting proliferation of colon cancer cells LoVo and a method for preparing the lawn pennywort herb liver healing tablet. The lawn pennywort herb is made by using 699g of lawn pennywort herb, 1398g of candolle pimpinella, 699g of oxalis corniculata and 209g of anemone rivularis as raw medicinal materials and is prepared by adopting supercritical extraction, such that the content of oleanolic acid is greatly improved.
Owner:JINAN XINSHIDAI MEDICINE SCI & TECH

Preparation method and application of Huixinkang tablet in medicine for inhibiting cell proliferation of breast tumor cells C127

InactiveCN104069211ATake a lot of medicineSmall dosePill deliveryAntineoplastic agentsLicorice rootsPolygonum
The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a preparation method and an application of a Huixinkang tablet. According to the preparation method, the Huixinkang tablet is prepared by taking 780g of uncaria rhynchophylla, 910g of rhodobryum roseum (Hedw.) Limpr.Mnium roseum Hedw., 26g of polygonum multiflorum, 260g of astragalus membranaceus, 26g of pseudo-ginseng, 650g of hawthorn and 260g of licorice root as raw medicinal materials in manners of supercritical extraction and microwave extraction, so that the content of ginsenoside Rg1 is greatly improved. The invention further provides the application of the Huixinkang tablet in preparation of a medicine for inhibiting the cell proliferation of breast tumor cells C127 in rats.
Owner:关军

Preparation method of Qingmei cold tablet and application of Qingmei cold tablet in drugs for inhibiting anus sarcoma cell S-180 from cell proliferation

InactiveCN103768210ATake a lot of medicineSmall doseAntipyreticAnalgesicsMedicineDicliptera
The invention belongs to the technical field of traditional Chinese medicines, and particularly provides a preparation method and application of a Qingmei cold tablet. The preparation method comprises the following steps: by using 200g of southernwood, 267g of finger citron, 134g of elsholtzia, 200g of dicliptera, 134g of licorice, 134g of cat's-foot and 267g of holly root as active pharmaceutical ingredients, carrying out supercritical extraction and microwave extraction so that the glycyrrhizic acid content is greatly enhanced. The invention also provides application of the Qingmei cold tablet in preparing drugs for inhibiting anus sarcoma cell S-180 from cell proliferation.
Owner:孔凡华

Popular searches

No bitterness Bad taste Good curative effect Play a synergistic role Take a small dose Small toxicity Little side effects Effective treatment Improve compliance
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com